He said the first batch of 200,000 doses will leave China on February 20.
They are expected to be the first Covid-19 vaccine to arrive in Thailand following a delay in shipments of the AstraZeneca vaccine procured by the Thai government.
"After the vaccine arrives, the Department of Medical Sciences will conduct random quality checks before it is used for inoculation," Anutin said.
He added that the Food and Drug Administration is poised to register the Sinovac vaccine for emergency use.
Sinovac said trials had shown around 50 per cent efficacy in preventing infection and 80 per cent efficacy in preventing cases requiring medical treatment.